PlatinumPlatinum🃏All Remoraid cards
Ask about Remoraid
Remoraid #90 Pokémon card from Platinum

Remoraid 90/127

Platinum

👁 Watch📊 Add to portfolioFree — no card required to register.
Find this card on eBay

Affiliate link · we may earn commission

Remoraid #90 from Platinum currently trades at $0.80 raw, with PSA 10 copies reaching $39.94 — a 49.9x grade premium.
Current Prices (USD)
Ungraded
$0.80
PSA 7
$13.75
PSA 8
$13.75
PSA 9
$13.75
PSA 10
$39.94
ACE 10
BGS 10 Black
$260.00
CGC 10 Pristine
$43.00
Compare on eBay

Affiliate link · we may earn commission

Quick price facts

Remoraid 90/127 from Platinum has a current raw market value of $0.80.

Current raw value
$0.80
PSA 9 value
$13.75
PSA 10 value
$39.94
PSA 10 premium vs raw
49.9× raw
View all cards from Platinum
Collector Intel
49.9x
Raw → PSA 10
High-risk grade
17.2x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

⚠️ High-variance grade. PSA 10 is 50x the raw price. The expected value accounts for the realistic probability.
$1
Buy Raw
~$25
Grading Fee
PSA Standard
$40
PSA 10 Value
+$14
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$1417.2x raw
PSA 10$4049.9x raw

Frequently asked questions

How much is Remoraid #90 from Platinum worth?+
Remoraid #90 from Platinum is currently worth Raw: $0.80, PSA 9: $13.75, PSA 10: $39.94 based on recent sold listings. Prices update daily from real eBay sales.
Is Remoraid #90 worth grading?+
The PSA 10 price of $39.94 is 49.9× the raw price of $0.80. After a ~$25 grading fee, a PSA 10 result would net approximately $39.14 — assuming the card grades a 10.
Where do PokePrices Remoraid #90 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.